Jeffrey Kadanoff is the Managing Director of Esplanade Equity. Prior to Esplanade, he was the Chief Financial Officer for Knight Therapeutics Inc. (TSX: GUD), a leading Canadian specialty pharmaceutical company, from its inception as a publicly listed company in February 2014 until October 2017. Prior to joining Knight Therapeutics Inc. he was a Principal with Bain & Company where he served as a strategy consultant for 14 years. Additionally, he was Vice President-Strategic Planning and Development at Reitmans (Canada) Limited.
Jeffrey holds a B. Eng. with Distinction in Chemical Engineering and a Minor in Management from McGill University, and an MBA with Distinction from INSEAD.
+1 (438) 794-1787